YEKEDÜZ, E. Et Al. 2022. Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study. European Journal of Clinical Pharmacology , vol.78, no.12 , 1973-1979.

YEKEDÜZ, E., Özbay, M. F., Çağlayan, D., Yıldırım, A., Erol, C., Yıldırım, H. Ç., ... Tunç, S.(2022). Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study. European Journal of Clinical Pharmacology , vol.78, no.12, 1973-1979.

YEKEDÜZ, EMRE Et Al. "Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study," European Journal of Clinical Pharmacology , vol.78, no.12, 1973-1979, 2022

YEKEDÜZ, EMRE Et Al. "Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study." European Journal of Clinical Pharmacology , vol.78, no.12, pp.1973-1979, 2022

YEKEDÜZ, E. Et Al. (2022) . "Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study." European Journal of Clinical Pharmacology , vol.78, no.12, pp.1973-1979.

@article{article, author={EMRE YEKEDÜZ Et Al. }, title={Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study}, journal={European Journal of Clinical Pharmacology}, year=2022, pages={1973-1979} }